Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK

This review (2008) retraces the 20-year scientific history of serotonin (5-HT) research in the UK.

Abstract of Gaddum and LSD

“The vasoconstrictor substance named serotonin was identified as 5-hydroxytryptamine (5-HT) by Maurice Rapport in 1949. In 1951, Rapport gave Gaddum samples of 5-HT substance allowing him to develop a bioassay to both detect and measure the amine. Gaddum and colleagues rapidly identified 5-HT in brain and showed that lysergic acid diethylamide (LSD) antagonized its action in peripheral tissues. Gaddum accordingly postulated that 5-HT might have a role in mood regulation. This review examines the role of UK scientists in the first 20 years following these major discoveries, discussing their role in developing assays for 5-HT in the CNS, identifying the enzymes involved in the synthesis and metabolism of 5-HT and investigating the effect of drugs on brain 5-HT. It reviews studies on the effects of LSD in humans, including Gaddum’s self-administration experiments. It outlines investigations on the role of 5-HT in psychiatric disorders, including studies on the effect of antidepressant drugs on the 5-HT concentration in rodent and human brain, and the attempts to examine 5-HT biochemistry in the brains of patients with depressive illness. It is clear that a rather small group of both preclinical scientists and psychiatrists in the UK made major advances in our understanding of the role of 5-HT in the brain, paving the way for much of the knowledge now taken for granted when discussing ways that 5-HT might be involved in the control of mood and the idea that therapeutic drugs used to alleviate psychiatric illness might alter the function of cerebral 5-HT.”

Author: Andy R. Green

Summary of Gaddum and LSD

The history of recent science can be evaluated in two ways: by examining the published literature and talking to the scientists involved in the research, or by obtaining their personal views of events, people and priority.

Although the personal recollections of scientists after retirement might be charming, they are often unreliable historically. A history based on published work alone can become a very dry affair, so Green hopes to give a flavour of some of the people involved.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK

https://doi.org/10.1038/bjp.2008.207

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Green, A. R. (2008). Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5‐HT in the UK. British journal of pharmacology154(8), 1583-1599.

Study details

Compounds studied
LSD

PDF of Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK